# Huatai Ruilian

> Huatai Ruilian is a VC fund in Beijing Shi backing Genetics, Therapeutics and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing Shi, China
- Total investments: 4
- Last investment: Apr 2021
- Lead investor: 0%
- Last updated: Aug 2026

Huatai Ruilian is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 2 | 50% |
| Therapeutics | 2 | 50% |
| Biotechnology | 2 | 50% |
| Pharmaceutical | 2 | 50% |
| Hardware | 1 | 25% |

11 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Porton Biologics | Porton Biologics provides end-to-end gene/therapy CDMO service for innovators from the early stage, IND filling, and commercial production. | $56.7M | Series A | Apr 16, 2021 |  |
| Porton Advanced Solutions | Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services. | $61.3M | Series A | Apr 16, 2021 |  |
| China Satellite Navigation and Communications Co., Ltd | China Satellite Navigation and Communications Co., Ltd is a is a commercial vehicle intelligent network technology service provider company. | $1.4M | Series A | Sep 13, 2018 |  |
| 352 | 352 is an air and water purification system provider company. | $28.3M | Series A | Sep 28, 2017 |  |

4 of 4 investments shown.

## Co-investors
- [GL Ventures](https://shizune.co/investors/profile/gl-ventures) — VC Fund, 2 deals together
- [Huimei Capital](https://shizune.co/investors/profile/huimei-capital) — VC Fund, 2 deals together
- [Momentum Venture](https://shizune.co/investors/profile/momentum-venture) — VC Fund, 2 deals together
- [State Development & Investment Corporation](https://shizune.co/investors/profile/state-development-investment-corporation-sdic) — VC Fund, 2 deals together
- [Atlas Capital](https://shizune.co/investors/profile/atlas-capital) — VC Fund, 1 deal together
- [BAI capital](https://shizune.co/investors/profile/bertelsmann-asia-investments) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Huatai Ruilian invest in?

Huatai Ruilian invests primarily in Genetics, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Huatai Ruilian last invest?

The most recent investment recorded for Huatai Ruilian closed in Apr 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co